Sae-Won Han

18PUBLICATIONS
126CO-AUTHORS
ChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 23, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Mar 23, 2026
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.

Michael Cecchini, Sae-Won Han, Soohyeon Lee

|Feb 26, 2026
CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells.

Hye Jeong Yun, Chan Ho Park, Dahye Yun

|Aug 26, 2025
Platform study of circulating tumor DNA directed adjuvant chemotherapy in colon cancer (CLAUDIA colon cancer, KCSG CO22-12).

Yongjun Cha, Sang-Hee Cho, Eun Young Park

|Dec 05, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.

Jayesh Desai, Guzman Alonso, Se Hyun Kim

Pageof 3

Frequent Collaborators

3 joint publications

Jeong Mo Bae

3 joint publications

Gyeong Hoon Kang

3 joint publications

Yong Sang Hong

3 joint publications

Tae-You Kim